|
Mawi DNA is honored to be recognized for this achievement and continues to develop innovative technologies for universal sample collection. “I strongly believe that science is simple and needs to be approached accordingly. Removing barriers to enable interdisciplinary collaborations is critical for accelerating innovation and driving new discoveries! I’m open to scientific collaborations and partnerships.”- Dr. El-Fahmawi After nearly a decade of focused effort and much trial and error, Dr El-Fahmawi was able to develop and commercialize the iSWAB™ sample collection system, founding his company, Mawi DNA Technologies. View the Global Health & Pharma Article
|
Candida Data Using iSWAB In Response to New Infectious Diseases...
A deadly fungal infection, Candida Auris, is becoming a serious threat. This drug-resistant strain is deadly for those with weakened immune systems and is spreading at an alarming rate. The READ MORE
Top Reasons to Ditch Your Current VTM. Upgrade your Viral…...
Mawi DNA has developed iSWAB-RC-EL, an FDA approved sample collection device for transport and storage of samples suspected of containing an infectious disease*. Why iSWAB-RC-EL is the superior op...
READ MOREMawi DNA Announces Dr. Bouzyk as New Board Member!...
It is with great delight and excitement that we announce that Dr. READ MORE